Health News Review
  • Sep 8 2014

    Competition between “cure” and “breakthrough” on MS story — in mice

    A paper in the journal Nature Communications reported on a mouse study of a condition similar to multiple sclerosis. Mice.  And mice only. But look at how it was reported.  There was competition betweenhow many stories would claim “breakthrough” versus how many would claim “cure.” The Daily Express in the UK:  “Could a cure for [...]

    1 Comment
  • Sep 4 2014

    Family’s pursuit of proton beam therapy is focus of international controversy

    Proton beam therapy – which I’ve written about many times – is in the headlines for new reasons, including: a little boy with brain cancer charges of denial of treatment “an international manhunt” extradition hearing a statement by the British Prime Minister A Google search comes up with more than 2,000 returns on the story.  [...]

    2 Comments
  • Sep 4 2014

    See it, stent it: the Oculostenotic Reflex

    A small, but important study was summarized in JAMA Internal Medicine last week, “How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients With Stable Angina.” It was an analysis of 40 discussions between patients and cardiologists about whether to pursue angiograms (catheters inject dye into the heart arteries so imaging can show blockages) [...]

    1 Comment
  • Sep 3 2014

    European Society of Cardiology added to News Release Wall of Shame

    The press office of the European Society of Cardiology has been busy with the organization’s big annual meeting that concludes its 5-day run in Barcelona today. But I regret to announce that I’m adding them to my News Release Wall of Shame for one of their news releases headlined, “Drinking tea reduces non-CV mortality by [...]

    4 Comments
  • Sep 3 2014

    After Barcelona buzz wears off, questions remain about new heart drugs

    From the big European Society of Cardiology annual meeting in Barcelona come these headlines: Cholesterol Drug Halves Heart Attack and Stroke in Early Test Magic Cholesterol Pill Halves Heart Attack Risk The first was from the New York Times, picking up a Reuters story. Seeing that, Yale’s Dr. Harlan Krumholz tweeted: “This @nytimes headline sends [...]

    1 Comment
  • Aug 24 2014

    Questions about the ice bucket challenge

    A story in the Cincinnati Enquirer, “Ice bucket challenge? Here’s where  your money goes,” is worth a look. It doesn’t make any statement about what’s right or wrong or good or bad about the campaign.  It simply states facts, based on what the reporter found on Guidestar.org.  Excerpts: “The (Amyotrophic Lateral Sclerosis – ALS) association [...]

    3 Comments
  • Aug 23 2014

    Robotic surgery company objects to tough journalism; objections & responses posted

    Men’s Health magazine deserves credit not only for its tough story, “What’s Wrong with Robotic Surgery?” by an excellent journalist, Laura Beil, earlier this year.  But when Intuitive Surgical, manufacturer of the DaVinci robotic surgical system, objected to the piece, Men’s Health posted a point-by-point response to the objections. A double dose of good journalism, [...]

    No Comments
  • Aug 22 2014

    Dr. Peter Bach on “Avoiding the Breast Cancer ‘Warrior’ Trap”

    I clearly remember struggling with if/what I should write about Amy Robach of ABC News and her on-air and online statements about her own breast cancer diagnosis and treatment – and what it might mean for other women. I finally decided, and published “There’s another side to the Amy Robach breast cancer story,” becoming one [...]

    1 Comment
  • Aug 22 2014

    Predatory journal: “good way to make an income & defraud scientific community”

    Applause for Tom Spears of The Ottawa Citizen for his piece, “Respected medical journal turns to dark side.” He begins: “A respected Canadian medical journal that was sold to offshore owners last year is now printing scientific junk for hire, but still trading on its original good name. Experimental & Clinical Cardiology was published in Oakville, Ont., [...]

    No Comments
  • Aug 22 2014

    Here’s how the new FDA-approved colon cancer test could have been covered

    Los Angeles Times business/consumer columnist David Lazarus writes, “A good alternative to having a colonoscopy?  Maybe not.” Excerpt: A Wisconsin company called Exact Sciences has launched a marketing campaign for its new product, Cologuard, which it hails as “the breakthrough test for colon cancer screening that’s as easy as going to the bathroom.” Although stool [...]

    No Comments